Pipeline
- By Model
- By Modality
By Model
| Platform | Model |
| VILLIORGAN™ | Discovery of new strains & Efficacy evaluation |
| IBD, Crohn’s disease, metabolic disorders | |
| Drug repurposing | |
| Viral infection | |
| CANORGAN™ | Brain cancer |
| Liver cancer | |
| Colon cancer | |
| Breast cancer | |
| Cervical cancer | |
| Melanoma | |
| PDC-derived cancer | |
| MASH | |
| TME |
By Modality
| Platform | Modality |
| VILLIORGAN™ | Small molecule |
Microbiome | |
| CANORGAN™ | ADC |
| CAR-T | |
Nanobody | |
Small molecule |